moa of glp-1 agonists A Closer Look at the Dermatological Profile Frontiers | GLP−1 receptor agonists

J Drug Deliv Ther 8

High IGF-1 Possible increased cancer risk, accelerated cell proliferation without adequate repair balance

HLC position: monitor

Behavioral strategies include self-monitoring of food intake and weight, stimulus control, problem-solving, and cognitive restructuring

BPC-157 Cosmetic Cream was formulated to moisturize and hydrate the skin, improving the appearance of skin texture.*

These may include: Injection site redness or tenderness Mild headaches or dizziness Nausea or digestive discomfort Temporary joint or muscle soreness Water retention (CJC) Histamine response: flushing, tingling, redness (CJC) Mild fever or chills (Thymosin Alpha-1) If symptoms persist or become uncomfortable, contact our Denver office before taking your next dose